StockTipsArenaBeta

BUY Gland Pharma Limited — Chandan Taparia, Motilal Oswal

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: BTST9 Sept 2026, 3:29 pm ISTvia CNBC Awaaz.

Entry₹3,026.2Inferred
Target₹3,100
Total upside +2.44% (call closed)
Stop loss₹2,980-1.53% risk
Exit₹2,98010 Sept 2026, 10:14 am
Stop-loss hit-1.53%
Follow Chandan Taparia for new calls(13% target hit, 72 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Sept 2026
3 supporting4 neutral2 opposing
Supports the BUY call (3)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·10 Sept · today

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

NewsEt-Markets·3 Sept · 6d ago

(opens in new tab)

Gland Pharma Block Deal: Fosun Pharma to sell 5% stake at ₹2,763/share

NewsCnbc-Tv18·3 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (4)

Fosun Pharma sells 4.5% stake in Gland Pharma for Rs 2,121 crore

NewsHbl·5 Sept · 4d ago

(opens in new tab)

Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore

NewsEt-Markets·4 Sept · 5d ago

(opens in new tab)

Block deal alert! Gland Pharma shares in focus as promoter Fosun to sell 5% stake for Rs 2,279 crore

NewsEt-Markets·4 Sept · 6d ago

(opens in new tab)

Gland Pharma Promoter Likely To Sell 5% Stake Via Rs 2,279 Crore Block Deal

NewsNdtv-Profit·3 Sept · 6d ago

(opens in new tab)
Weighs against the BUY call (2)

Gland Pharma shares fall after ₹2,100 crore block deal; Promoter likely seller

NewsCnbc-Tv18·4 Sept · 6d ago

(opens in new tab)

Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

NewsEt-Markets·4 Sept · 6d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Chandan Taparia, Motilal Oswal

Every call and its outcome